Table 3.
Healthcare professionals’ responses to 15 attitudinal statements on adverse drug reaction (ADR) reporting, Uganda, 2013
| Statement | Agree | Neutral | Disagree |
|---|---|---|---|
| Serious ADRs are well documented by the time a drug is marketed | 820 (61.7) | 166 (12.5) | 343 (25.8) |
| It is nearly impossible to determine whether a drug is responsible for a particular adverse reaction | 527 (39.8) | 189 (14.3) | 607 (45.9) |
| I would only report an ADR if I were sure that it was related to the use of a particular drug | 833 (63.6) | 138 (10.6) | 338 (25.8) |
| The one case of an ADR that an individual health worker might see makes no significant contribution to medical knowledge | 210 (16.2) | 122 (9.4) | 966 (74.4) |
| I read articles about adverse drug reactions with interest | 824 (63.3) | 180 (13.8) | 298 (22.9) |
| I have a professional obligation to report ADRs | 1000 (76.3) | 143 (10.9) | 168 (12.8) |
| Reporting ADRs puts my career at risk | 186 (14.3) | 126 (9.7) | 989 (76.0) |
| It is only necessary to report serious or unexpected ADRs | 466 (35.7) | 129 (9.9) | 709 (54.4) |
| I do not have time to complete an ADR report form | 143 (10.9) | 208 (15.8) | 963 (73.3) |
| I do not have the time to actively look for ADRs while at work | 195 (14.8) | 152 (11.6) | 968 (73.6) |
| I do not know how information reported in an ADR form is used | 596 (45.4) | 194 (14.8) | 522 (39.8) |
| I talk with pharmaceutical companies about possible ADRs with their drugs | 290 (22.2) | 202 (15.5) | 813 (62.3) |
| I think the best way to report ADRs is by publishing in medical literature | 701 (53.4) | 238 (18.1) | 374 (28.5) |
| I should be financially reimbursed for providing the ADR service | 349 (26.7) | 199 (15.3) | 757 (58.0) |
| I would be more likely to report ADRs if there were an easier method | 896 (67.9) | 169 (12.8) | 254 (19.3) |